Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: CALGB 50904 Principal Investigator: Bartlett, Nancy
Title: A Randomized Phase II Trial of Ofatumumab and Bendamustine vs. Ofatumumab, Bortezomib and Bendamustine in Patients with Untreated Follicular Lymphoma
Phase: II Disease Site: Non-Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions		 South County
Map and Directions		 St. Peters
Map and Directions		 West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to find out what effects (good and/or bad) treatment with the combination of ofatumumab and bendamustine or the combination of ofatumumab, bendamustine, and bortezomib has on patients and their lymphoma.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)